$56.5 Million
Marker Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$91.7 Million
Infinity Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$69.4 Million
Kaleido Biosciences
Confidentially Marketed Follow-On Offering
Active Bookrunner
$75.6 Million
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$50.6 Million
Fulcrum Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$74.5 Million
Gamida Cell Ltd.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$52.8 Million
Catalyst Biosciences, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$172.6 Million
Arcturus Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$73.8 Million
MeiraGTx Holdings plc
Confidentially Marketed Follow-On Offering
Active Bookrunner
$51.7 Million
Milestone Pharmaceuticals Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Biopharma

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.